Nearly five dozen 2019 models meet stricter criteria to qualify for a 2019 TOP SAFETY PICK+ or TOP SAFETY PICK award from the Insurance Institute for Highway Safety. The 30 first-tier “plus” award winners earn the highest rating for passenger-side protection in a small overlap front crash and have good-rated available headlights, while the 27 winners of the second-tier award qualify with an acceptable or higher rating in the newest IIHS crash test and the nighttime headlight evaluation.
All 57 vehicles in this elite group earn good ratings in the Institute’s five other crashworthiness evaluations and have an available automatic emergency braking system that rates advanced or superior for front crash prevention.
IIHS now requires a good rating in the passenger-side small overlap front test to earn a 2019 TOP SAFETY PICK+ versus an acceptable or good rating for the 2018 award. An acceptable or good rating in the passenger-side test is a new criterion to earn a 2019 TOP SAFETY PICK.
This marks the sixth time that IIHS has raised the bar to earn the TOP SAFETY PICK+ award since introducing it in the 2013 model year to recognize vehicles that offer a superior level of safety. The TOP SAFETY PICK accolade launched in the 2006 model year to help consumers identify vehicles with the highest ratings. Over the years, IIHS has added to and strengthened criteria for both awards to encourage manufacturers to speed up safety advances.
JNA (Jewellery News Asia), organiser of the prestigious JNA Awards, has announced the much-anticipated list of Honourees or shortlisted finalists across 15 categories for 2015. A total of 49 Honourees representing 31 companies from 10 countries/regions have been shortlisted.
The JNA Awards is supported by Headline Partners Rio Tinto Diamonds and Chow Tai Fook, together with Honoured Partners Diarough Group, Gübelin Group, Israel Diamond Institute Group of Companies, Shanghai Diamond Exchange and Guangdong Land Holdings Limited (GDLAND).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7559651-jna-awards-2015/
Content Marketing World NYC – a unique one-day master class – will send you home with the strategy and the know-how you need to create exceptional content that will engage your audience and grow your business.
This roll-up-your-sleeves workshop is brought to you by the force behind Content Marketing World (a production of the Content Marketing Institute), in partnership with Target Marketing and Publishing Executive. Join us and you’ll find an intimate (and casual) setting where today’s content marketing thought-leaders will provide you with the tools you need in order to develop and deliver an effective content strategy.
To view Multimedia News Release, go to http://www.multivu.com/players/English/58748-content-marketing-world-nyc-2012/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
The Lincoln Continental, the Mercedes-Benz E-Class and the Toyota Avalon come out at the top of a group of six large cars recently evaluated by the Insurance Institute for Highway Safety.
The three cars qualify for TOP SAFETY PICK+, the Institute’s highest award. The Tesla Model S, the Chevrolet Impala and the Ford Taurus fall short of any award because they each earn only an acceptable rating in the small overlap front test.
Vehicles qualify for either the TOP SAFETY PICK or TOP SAFETY PICK+ award if they have good ratings from IIHS in five crashworthiness tests — small overlap front, moderate overlap front, side, roof strength and head restraints — and an available front crash prevention system that earns a superior or advanced rating. To qualify for TOP SAFETY PICK+, a vehicle also must come with good or acceptable headlights
The ranks of top-rated booster seats continue to grow as manufacturers design models to earn high marks in the Insurance Institute for Highway Safety’s annual booster seat evaluations, plus offer the style and convenience parents look for when it’s time to pick a safe seat for their booster-age children.
Among the 41 models new for 2014, there are 27 BEST BET seats — more than in any prior year — and three GOOD BETs. Eight boosters are in a category the Institute calls “Check Fit,” and there are three new models that the Institute doesn’t recommend using as boosters. Prices for BEST BET boosters start around $25 and go up to about $370, depending on features, and several models are LATCH compatible.
Holland America Line turns its culinary programming up a notch with the introduction of dynamic shipboard cooking shows produced in partnership with the long-running public television show America’s Test Kitchen, the most popular how-to-cook show on TV. Holland America Line is a sponsor of America’s Test Kitchen on public television, and is proud to make this experience possible at sea. The initiative was announced today in New York City at a press conference at the prestigious Institute of Culinary Education.
Holland America Line’s shipboard Culinary Arts Center will be transformed to replicate the television set where the prominent America’s Test Kitchen TV shows are recorded for broadcast by more than 350 public television stations nationwide. Designed specifically for Holland America Line, the shipboard shows will be hosted by Holland America Line chefs trained by America’s Test Kitchen culinary experts. Shipboard cooking demonstrations and hands-on workshops — with topics ranging from shaping Asian dumplings to making the perfect pie crust — will combine foolproof, accessible recipes and cooking techniques that are rooted in the rigorous testing and science-based approach of America’s Test Kitchen.
To view the multimedia release go to:
http://www.multivu.com/players/English/7363858-americas-test-kitchen-joins-holland-america/
WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis.
“Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
Thirteen out of 16 new booster seats for 2017 earn the Insurance Institute for Highway Safety's highest rating of BEST BET, bringing the total number of boosters on the market with that designation to 118.
The BEST BET rating means a booster provides good safety belt fit for typical 4 to 8 year-olds in almost any car, minivan or SUV. Boosters that are rated GOOD BETs provide acceptable belt fit in almost any vehicle, while those rated Check Fit could work for some children in some vehicles. Seats designated "Not Recommended" don’t provide good belt fit and should be avoided.
Buckling precious cargo into a late-model vehicle has gotten a bit easier in the past year, the Institute’s LATCH ease-of-use ratings show.
IIHS launched its ratings of child seat installation hardware in vehicles in June 2015. Out of 102 vehicles rated at that time, the majority were poor or marginal. Today, a total of 170 current models have been evaluated, and most are good or acceptable. Three models — the Audi Q7, Lexus RX and Toyota Prius — earn the top rating of good+, a distinction that no vehicle achieved last year.
A properly installed, age-appropriate child restraint can protect a child much better in a crash than a safety belt alone. LATCH, which stands for Lower Anchors and Tethers for Children, is intended to make it easier for caregivers to install child restraints properly. Child restraints installed with LATCH are more likely to be put in correctly than restraints installed using the vehicle safety belt, IIHS research has shown.
Even with LATCH, installation errors are common. The Institute’s ratings are based on key ease-of-use criteria that have been shown to minimize mistakes.
A new online resource is now available to help people recognize and find high quality care for alcohol use disorder, which affects more than 15 million adults in the United States. The Alcohol Treatment Navigator, designed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, is a comprehensive, yet easy-to-use tool to help individuals and their loved ones navigate the often-complicated process of choosing treatment for alcohol problems. With many treatment options available, the navigator makes the search easier by telling them what they need to know - and what they need to do – to find appropriate, quality care.
“We developed this tool to help address the alcohol ‘treatment gap,’” said NIAAA Director George F. Koob, Ph.D. “In any given year, less than 10 percent of individuals diagnosed with alcohol use disorder receive treatment, and many of them do not receive the type of care that best fits their needs. A big reason for that, we believe, is that people with alcohol use disorder often don’t know where to turn for help. The Alcohol Treatment Navigator offers a comprehensive strategy to help people search for professionally-led, evidence-based alcohol treatment, which should improve their chances for success.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8179051-niaaa-alcohol-treatment-navigator/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
